Objective: The goal of the study was to determine risk factors for maternal cardiac failure in pregnancy complicated with dilated cardiomyopathy (DCM).
Introduction
Dilated cardiomyopathy (DCM) is characterized by ventricular enlargement and systolic cardiac dysfunction, especially on the left side. 1 In association with pregnancy, there are two types of DCM:
peripartum cardiomyopathy (PPCM) and DCM not categorized as PPCM. 2, 3 PPCM is distinguishable from DCM-complicated pregnancy by the time of onset, as PPCM is defined as occurring in the last month of pregnancy until 5 months after delivery and by the causal relationship, with PPCM exclusively associated with cardiac lesions such as valve or coronary disease. 4, 5 Elkayam et al. defined 'pregnancy-associated (PA) cardiomyopathy' as a condition that occurred during pregnancy except in the last month and reported similar clinical characteristics to those of PPCM. Morales et al. 6 found common genetic mutations in PPCM and DCM. At present, however, PPCM and DCM-complicated pregnancy are considered to be different disorders.
There have been many studies of the etiology, 7 epidemiology, 8 prognosis 9 and treatment 10 of PPCM, but only a few studies of DCM-complicated pregnancy. 11, 12 Bernstein and Magriples 12 compared the cardiac outcomes of DCM-complicated pregnancy with PPCM and Grewal et al. 11 compared similar outcomes in cases of DCM, with and without pregnancy. DCM-complicated pregnancy showed a better prognosis than PPCM, but a worse prognosis than non-pregnant DCM. These results indicate a negative impact of pregnancy on the cardiac outcome of DCM. Therefore, the current retrospective study of DCM-complicated pregnancy was carried out to determine parameters that are significantly associated with cardiac outcome at 1 year after delivery, to examine whether early termination of pregnancy preserves cardiac function and to establish whether the outcome of PA DCM is worse than that of pre-pregnancy DCM.
Methods
We examined the records of 29 women with DCM who were pregnant from January 1982 to December 2007 and visited the National Cerebral and Cardiovascular Center in Japan. DCM was defined as left ventricle end-diastolic dimension (LVDd)X48 mm and/or fractional shortening (%FS)p30% on echocardiography, using one of the criteria for PPCM published by the Journal of the American Medical Association. 5, 13, 14 Patients with PPCM defined by Demakis' criteria of (1) development of cardiac failure in the last month of pregnancy or within 5 months of delivery, (2) absence of a determinable etiology for the cardiac failure and (3) absence of demonstrable heart disease before the last month of pregnancy were excluded. 4 Those with structural heart disease and secondary LV dysfunction were also excluded. 5, 13, 14 The 29 women (29 pregnancies) were followed until 1 year after delivery. Artificial abortion cases were followed until at least 20 months after abortion to match the time course of delivery cases. Echocardiography was performed at least once in each trimester to evaluate cardiac function, with a focus on LV %FS and LVDd. Demographic data were collected from each patient's chart for maternal age, parity, presence or absence of hypertension, diabetes mellitus, history of multiple pregnancies and body mass index. For pregnancy data, the delivery mode (Cesarean section or vaginal delivery), gestational weeks of delivery, birth weight and the infant's prognosis were collected. Changes of %FS, LVDd and QJ;New York Heart Association (NYHA) classification were also investigated. Patients with cardiac dysfunction and marked limitation of physical activity were defined as having heart failure.
Patients who died or had end stage heart failure of NYHA class III and IV were placed in a poor prognosis group (n ¼ 6). All other patients were placed in the good prognosis group (n ¼ 23). The 29 cases were also categorized into two groups based on the timing of the initial diagnosis of DCM, the PA and non-PA groups. Patients in the PA group had DCM diagnosed during the first 8 months of pregnancy, whereas those in the non-PA group had been diagnosed with DCM before pregnancy.
Hypertension was defined as systolic blood pressure X140 mm Hg or diastolic blood pressure X90 mm Hg or a requirement for antihypertensive agents. 15 Diabetes mellitus was defined as the presence of a fasting plasma glucose level X126 mg dl À1 , a hemoglobin type A1c fraction X6.5%, a plasma glucose level X95, X180 and X155 mg dl À1 , before and 1 and 2 h after a 75 g oral glucose tolerance test, respectively (a patient meeting two of these three criteria was judged to be positive); or a requirement for antidiabetic drugs. 16 The study was exempted from Committee on Human Research approval (National Cerebral and Cardiovascular Center), because there no longer exists a key or code sheet relating the identity of each patient to his or her private health information.
Statistical analysis
For continuous variables, a Student's t-test was performed for analysis of normally distributed data and a Wilcoxon test was used for data that were not normally distributed. w 2 -test and Fisher's exact test were performed for comparing categorical variables between the two groups. All statistical analyses were performed using SAS 9.2 (SAS Institute, Cary, NC, USA). A P-value of 0.05 was considered statistically significant.
Results
Comparison of PA DCM and non-PA DCM Among the 29 subjects, there were 14 cases of PA DCM and 15 cases of non-PA DCM (Table 1) . Of the 14 cases of PA DCM, 12 were diagnosed in the first trimester and 2 in the second trimester. Ten of the PA DCM cases presented with general fatigue and dyspnea on light exertion, two had night dyspnea and two had dyspnea and increasing leg and pretibial edema. All cases were diagnosed as DCM by echocardiography. The cases of non-PA DCM were diagnosed at a median age of 16 years, at 6 months old in two cases, at 2 to 3 years old in four cases, at 12 to 20 years old in five cases and at 20 to 30 years old in four cases. DCM had been confirmed before the first conception in all these cases. During pregnancy the first echo was performed in the first trimester in all cases. The %FS was significantly lower in the PA group than in the non-PA group (17.5 versus 27.4%, P<0.005). The LVDd was larger in the PA group, but the difference was not significant (P ¼ 0.15), and the incidence of heart failure was significantly higher in the PA group (6/14 versus 0/15, P<0.005; Table 2 ). The gestational weeks of delivery and birth weight of the newborn were both significantly lower in the PA group (34.0±3.5 versus 37.8±1.0 weeks, P<0.01; 2146 ± 579 versus 2815 ± 352 g, P<.01).
Comparison of cases with poor and good prognoses
More cases in the good prognosis group had %FSX22% throughout the observed course, compared with the poor prognosis group (14/15 (93%) versus 0/6 (0%), P<0.0001) (Figure 1 ). In the The %FS of the first test during pregnancy was significantly lower in PA cases than in non-PA cases (17.5 versus 27.4%, P<0.005). LVDd was larger in PA cases than in non-PA cases, but the difference was not significant (P ¼ 0.15).
Risks in pregnancy with dilated cardiomyopathy S Katsuragi et al eight induced-abortion cases, %FS ranged from 10 to 22% and was unchanged at 20 months after abortion. LVDd did not differ significantly between the good and poor prognosis groups (Figure 2 ), but was significantly elongated at the initial examination during pregnancy in two patients who subsequently died. In an receiver operating characteristic analysis of the relationship of the %FS value to poor maternal prognosis, the area under the curve (AUC) was 0.9778 and the value of %FS that showed the best sensitivity (one specificity) was 20.5.
Changes in NYHA class
In the 21 delivery cases, all the non-PA patients remained in NYHA class I throughout the observed course (Figure 3 ). Of the 10 PA delivery cases, 9 were in NYHA class I early in pregnancy. However, the NYHA class worsened as pregnancy progressed, except in one case, three patients died due to severe heart failure, three were in class II and three were in class III or IV with severe heart failure. All of the eight abortion cases had maintained the same NYHA class (six in class I, two in class II) at 20 months after abortion.
Discussion
The analysis of risk factors for maternal outcome in patients with DCM-complicated pregnancy showed that a low %FS and onset of DCM during pregnancy increased the risk of heart failure at 1 year after delivery.
Left ventricular fractional shortening LV %FS and LVDd are predictive factors for poor prognosis in DCM among non-pregnant patients. 17, 18 Our cases with decreased LV function are clearly distinguishable from PPCM, as patients with cardiac dysfunction that developed early in pregnancy are included in our study, whereas such cases are generally excluded from a PPCM cohort. Low cardiac function at the time of diagnosis of PPCM is a predictive factor for mortality. 3, [19] [20] [21] [22] Witlin et al. 23 reported that six of seven patients with severe PPCM 
Figure 1 Longitudinal changes of fractional shortening (%FS)
. Most cases with a good prognosis (full line) had a higher %FS than cases with a poor prognosis (dotted line). In abortion cases, %FS ranged from 10 to 22% when abortion was induced and these values had not changed at 20 months after abortion. PA, pregnancy associated; non-PA, non-pregnancy associated.
Risks in pregnancy with dilated cardiomyopathy S Katsuragi et al (LVDdX60 mm and %FSp21%) did not regain normal cardiac function in follow-up echocardiography and Chapa et al. 14 found that %FS <20% [24] [25] [26] and LVDdX60 mm at the time of diagnosis were associated with a more than three-fold risk for persistent LV dysfunction. In our patients, %FS <22% at the first test during pregnancy was predictive of worse cardiac function in late pregnancy and/or after delivery. In contrast, women who underwent abortion maintained cardiac function and NYHA functional class at 20 months after abortion. These results indicate that early termination of pregnancy prevents deterioration of cardiac function through avoidance of the stress and burden of pregnancy.
Pregnancy-associated DCM
Compared with women diagnosed with DCM before pregnancy, those diagnosed with DCM in early pregnancy had a higher incidence of heart failure and a poorer prognosis. In a comparison of maternal outcomes of 23 women with PPCM and 8 women with preexisting DCM, of the same age, Bernstein and Magriples 12 found that the outcomes of PPCM cases were significantly worse than those for preexisting DCM cases, with incidences of poor prognoses of 52 and 12%, respectively. Our patients are not comparable to the PPCM patients, as PPCM is defined as development of cardiac failure in the last month of pregnancy or within 5 months after delivery and thus has an acute clinical course. [19] [20] [21] Early diagnosis and initiation of medication can lead to improvement of LV systolic function and the outcome of pregnancy. 19, 20 In the non-PA group, seven patients received anticardiac remodeling therapy, with beta-blockers or diuretics before conception. This treatment may have led to the good maternal prognosis in this group. However, diagnosis of DCM and mildly decreased LV function in early pregnancy is very difficult if the Figure 2 Longitudinal changes of left ventricle end-diastolic dimension (LVDd). In delivery cases, LVDd did not differ significantly between those with a good prognosis (full line) and a poor prognosis (dotted line). However, LVDd was significantly elongated in the initial test during pregnancy in two patients who subsequently died. PA, pregnancy associated; non-PA, non-pregnancy associated. Figure 3 Changes of New York Heart Association (NYHA) class. All non-pregnancy associated (non-PA) cases (full line) and abortion cases maintained the same NYHA class throughout the study period. However, the NYHA class worsened as pregnancy progressed in most pregnancy associated (PA) cases (dotted line).
Risks in pregnancy with dilated cardiomyopathy S Katsuragi et al patient is free from symptoms, because echocardiography is seldom performed in early pregnancy in women with an apparently normal heart before pregnancy. We performed follow-up echocardiography when a pregnant woman complained of even mild fatigue, palpitation or dyspnea after DCM was diagnosed. However, such non-specific complaints are common in pregnant women without heart disease; therefore, patients with DCM and mild symptoms in early pregnancy may go unnoticed in routine medical examinations. Thus, some of our patients with mild to moderate dyspnea who were diagnosed with heart failure early in pregnancy might otherwise have been diagnosed with apparent heart failure late in pregnancy or after delivery. This assessment is consistent with the analysis by Elkayam et al.
3 of 123 women with cardiomyopathy diagnosed during pregnancy or in the postpartum period. That is, the clinical presentation and outcome of patients with PA cardiomyopathy diagnosed early in pregnancy are similar to those of patients with traditional PPCM. Therefore, these two conditions may represent a continuum of the same disease.
NYHA classification
The NYHA class I rating is used as the general standard for guidance of women with DCM, who want to become pregnant. In the current study, patients who had end stage heart failure or died late in pregnancy or after delivery were classified into NYHA class I in five cases and class II in one case in early pregnancy. These results indicate that NYHA class I is requisite for continuation of pregnancy, but cannot guarantee a good clinical outcome for mother and infant. Regardless of symptoms, echocardiographic findings of cardiac function (especially %FS) are necessary for prediction of the outcome of pregnancy.
Limitations
The patients with non-PA DCM performed better than the cohort with PA DCM. However, a selection bias may have been present, as we only studied patients who chose to pursue a pregnancy. Further, as our institution is a referral center for pregnancies with cardiovascular disease, some severe DCM cases that occurred during pregnancy were emergency maternal transfers to our center. These referrals may partly account for the worse cardiac performance and poorer maternal prognosis of patients with PA DCM, compared with those with non-PA DCM.
Conclusion
A low %FS (<22%) after conception and onset of DCM in early pregnancy are risk factors for a poor outcome in pregnancy complicated with DCM. Women who underwent abortion maintained cardiac function and NYHA functional classification over time, even though the %FS was low. The NYHA class in early pregnancy is not a predictor for maternal prognosis in women with DCM.
